Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Innate Pharma S.A. IPHYF

Set alert

Price alert · IPHYF

All alert types
2.25 USD +0.74 +49.11%

At close · Oct 30

2.18 Day range 2.25
1.37 52-week range 2.25
YTD
+4.65%
1 year
+12.50%
Open
2.18
Prev close
1.51
Mkt cap
251.33M
Vol
200
Avg vol
15
EPS
-0.59
P/E
0.00
More statistics
Low
2.18
High
2.25
Earnings
Mar 21, 2024

6M chart

Chart tools
Interval
1m5m15m30m

Signals (9)
NameDateAgo
MACD: Buy SignalOct 22, 20261 week ago
MACD: Sell SignalOct 2, 20261 month ago
RSI: OversoldOct 2, 20261 month ago
MACD: Buy SignalJun 30, 20264 months ago
MACD: Sell SignalMay 28, 20265 months ago
SMA: BearishMay 27, 20265 months ago
SMA: BullishMay 14, 20265 months ago
SMA: BullishMay 14, 20265 months ago
RSI: OverboughtMay 14, 20265 months ago

Financial health

Altman Z-Score

-21.86 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -3.3×
FY 2016: 63.0×FY 2017: -5.3×FY 2018: 139×FY 2019: -18.8×FY 2020: -326×FY 2021: -6.7×FY 2022: -4.2×FY 2023: -28.5×FY 2024: -4.6×FY 2025: -3.3×
FY 2016 5y median -4.6× FY 2025
P/S 58.7×
FY 2016: 13.9×FY 2017: 7.9×FY 2018: 5.3×FY 2019: 5.6×FY 2020: 3.9×FY 2021: 25.1×FY 2022: 4.9×FY 2023: 3.5×FY 2024: 18.0×FY 2025: 58.7×
FY 2016 5y median 18.0× FY 2025
P/B -7.5×
FY 2016: 9.1×FY 2017: 3.0×FY 2018: 2.5×FY 2019: 1.8×FY 2020: 1.7×FY 2021: 2.8×FY 2022: 4.5×FY 2023: 4.2×FY 2024: 25.7×FY 2025: -7.5×
FY 2016 5y median 4.2× FY 2025
P/FCF -3.1×
FY 2016: -16.9×FY 2017: -4.7×FY 2018: -12.5×FY 2019: -12.8×FY 2020: -4.3×FY 2021: -5.1×FY 2022: -12.0×FY 2023: -6.2×FY 2024: -31.1×FY 2025: -3.1×
FY 2016 5y median -6.2× FY 2025
EV/EBITDA -3.3×
FY 2016: 56.3×FY 2017: -3.8×FY 2018: 22.1×FY 2019: 11.3×FY 2020: 2.6×FY 2021: -5.7×FY 2022: -16.4×FY 2023: -24.5×FY 2024: -4.1×FY 2025: -3.3×
FY 2016 5y median -5.7× FY 2025
EV/Sales 56.7×
FY 2016: 10.9×FY 2017: 5.0×FY 2018: 3.5×FY 2019: 3.0×FY 2020: 2.2×FY 2021: 20.2×FY 2022: 4.1×FY 2023: 3.0×FY 2024: 15.2×FY 2025: 56.7×
FY 2016 5y median 15.2× FY 2025
FCF Yield -32.3%
FY 2016: -5.9%FY 2017: -21.1%FY 2018: -8.0%FY 2019: -7.8%FY 2020: -23.4%FY 2021: -19.6%FY 2022: -8.3%FY 2023: -16.2%FY 2024: -3.2%FY 2025: -32.3%
FY 2016 5y median -16.2% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 13.4%FY 2017: -105.3%FY 2018: 12.9%FY 2019: 34.5%FY 2020: 28.8%FY 2021: -184.1%FY 2022: 12.1%FY 2023: 9.1%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 12.1% FY 2025
Operating Margin -1917.7%
FY 2016: 13.5%FY 2017: -122.5%FY 2018: 6.4%FY 2019: -39.2%FY 2020: 1.5%FY 2021: -394.9%FY 2022: -115.7%FY 2023: -20.6%FY 2024: -408.6%FY 2025: -1917.7%
FY 2016 5y median -394.9% FY 2025
Net Margin -1764.5%
FY 2016: 22.5%FY 2017: -148.3%FY 2018: 3.8%FY 2019: -30.1%FY 2020: -91.7%FY 2021: -436.0%FY 2022: -117.1%FY 2023: -12.3%FY 2024: -392.0%FY 2025: -1764.5%
FY 2016 5y median -392.0% FY 2025
ROE 226.6%
FY 2016: 14.7%FY 2017: -56.3%FY 2018: 1.8%FY 2019: -9.5%FY 2020: -41.0%FY 2021: -49.2%FY 2022: -107.3%FY 2023: -14.6%FY 2024: -560.0%FY 2025: 226.6%
FY 2016 5y median -49.2% FY 2025
ROIC -133.9%
FY 2016: 3.6%FY 2017: -21.9%FY 2018: 2.0%FY 2019: -9.6%FY 2020: 0.4%FY 2021: -21.9%FY 2022: -34.1%FY 2023: -8.8%FY 2024: -59.4%FY 2025: -133.9%
FY 2016 5y median -34.1% FY 2025
ROA -78.4%
FY 2016: 4.5%FY 2017: -19.0%FY 2018: 0.7%FY 2019: -5.2%FY 2020: -20.8%FY 2021: -19.7%FY 2022: -28.0%FY 2023: -4.3%FY 2024: -44.5%FY 2025: -78.4%
FY 2016 5y median -28.0% FY 2025

Growth (YoY)

Revenue -77.9%
FY 2016: 213.6%FY 2017: -41.9%FY 2018: 144.8%FY 2019: -13.7%FY 2020: 1.2%FY 2021: -82.6%FY 2022: 309.8%FY 2023: 24.2%FY 2024: -79.5%FY 2025: -77.9%
FY 2016 FY 2025
Operating Income -3.6%
FY 2016: 170.3%FY 2017: -628.1%FY 2018: 112.9%FY 2019: -625.7%FY 2020: 104.0%FY 2021: -4532.3%FY 2022: -20.1%FY 2023: 77.9%FY 2024: -307.1%FY 2025: -3.6%
FY 2016 FY 2025
EPS (diluted) 9.8%
FY 2016: 276.9%FY 2017: -487.0%FY 2018: 105.8%FY 2019: -697.3%FY 2020: 96.6%FY 2021: -5328.6%FY 2022: -28.1%FY 2023: 87.7%FY 2024: -577.8%FY 2025: 9.8%
FY 2016 FY 2025
Free Cash Flow -625.6%
FY 2016: -123.1%FY 2017: -17.0%FY 2018: 37.2%FY 2019: 10.3%FY 2020: -107.0%FY 2021: 5.2%FY 2022: 66.1%FY 2023: -72.2%FY 2024: 79.1%FY 2025: -625.6%
FY 2016 FY 2025

Financial Health

Current Ratio 1.3×
FY 2016: 3.0×FY 2017: 1.9×FY 2018: 1.6×FY 2019: 2.0×FY 2020: 3.8×FY 2021: 1.7×FY 2022: 3.4×FY 2023: 3.7×FY 2024: 2.6×FY 2025: 1.3×
FY 2016 5y median 2.6× FY 2025
Quick Ratio 1.3×
FY 2016: 3.0×FY 2017: 1.8×FY 2018: 1.6×FY 2019: 1.9×FY 2020: 3.8×FY 2021: 1.7×FY 2022: 3.4×FY 2023: 3.7×FY 2024: 2.6×FY 2025: 1.3×
FY 2016 5y median 2.6× FY 2025
Debt / Equity -1.0×
FY 2016: 0.1×FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.4×FY 2022: 0.8×FY 2023: 0.8×FY 2024: 3.5×FY 2025: -1.0×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: -15.7×FY 2017: 2.1×FY 2018: -11.8×FY 2019: -10.2×FY 2020: -2.0×FY 2021: 1.4×FY 2022: 3.4×FY 2023: 4.1×FY 2024: 0.8×FY 2025: 0.1×
FY 2016 5y median 1.4× FY 2025
Interest Coverage -17.1×
FY 2016: 61.1×FY 2017: -354×FY 2018: 50.5×FY 2019: -133×FY 2020: 3.2×FY 2021: -153×FY 2022: -199×FY 2023: -19.8×FY 2024: -91.1×FY 2025: -17.1×
FY 2016 5y median -91.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31